Knife River Corp Ordinary Shares KNF 深 沪
已收盘 08-29 16:00:00 美东时间
81.00
+0.110
+0.14%
华盛通- 最 高82.33
- 今 开80.96
- 成交量 79.56万股
- 最 低 80.4175
- 昨 收 80.89
- 总市值 45.90亿
- 52周最高 108.83
- 市盈率 静 22.83
- 换手率 1.40%
- 52周最低 74.505
- 委 比 -95.12%
- 总股本 5666.42万
- 历史最高 108.83
- 量 比 1.01
- 振 幅 2.36%
- 历史最低 33.6712
- 每 手 1
- 风险率 8.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Peering Into Knife River Holding's Recent Short Interest
Knife River Holding's (NYSE:KNF) short percent of float has risen 11.51% since ...
08-13 00:00
Deep Dive Into Knife River Holding Stock: Analyst Perspectives (4 Ratings)
4 analysts have expressed a variety of opinions on Knife River Holding (NYSE:KN...
08-12 05:01
Wells Fargo Maintains Overweight on Knife River Holding, Raises Price Target to $97
Wells Fargo analyst Gabe Hajde maintains Knife River Holding (NYSE:KNF) with a Overweight and raises the price target from $96 to $97.
08-11 21:51
Knife River Holding Lowers FY2025 Sales Guidance from $3.250B-$3.450B to $3.100B-$3.300B vs $3.295B Est
Knife River Holding (NYSE:KNF) lowers FY2025 sales outlook from $3.250 billion-$3.450 billion to $3.100 billion-$3.300 billion vs $3.295 billion estimate.
08-05 19:04
Knife River Holding Q2 EPS $0.89 Misses $1.47 Estimate, Sales $833.800M Miss $902.779M Estimate
Knife River Holding (NYSE:KNF) reported quarterly earnings of $0.89 per share which missed the analyst consensus estimate of $1.47 by 39.46 percent. This is a 35.04 percent decrease over earnings of $1.37 per share from
08-05 19:03
Earnings Scheduled For August 5, 2025
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
08-05 16:32
What to Expect from Knife River Holding's Earnings
Knife River Holding (NYSE:KNF) is set to give its latest quarterly earnings rep...
08-04 23:05
Wells Fargo Maintains Overweight on Knife River Holding, Lowers Price Target to $96
Wells Fargo analyst Gabe Hajde maintains Knife River Holding (NYSE:KNF) with a Overweight and lowers the price target from $114 to $96.
07-29 22:32
美股大行评级 | 超配！Hinge Health获多家大行首予评级； Oppenheimer上调Mate目标价从665美元升至775美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1141651881139785729.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Ascendiant Capital：维持SurgePays Inc(SURG)"买入"评级，目标价从8.75美元升至9美元</p> <p>• Ascendiant Capital：维持LiqTech Internatio
06-17 09:46
美股大行评级 | 潜在涨幅434.95%！VNRX获Jones Trading首予"买入"评级，目标价3美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139478829918380033.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持Metsera(MTSR)"买入"评级，目标价从56美元升至62美元</p> <p>• 摩根大通：维持Avidity Biosciences(RNA)"超配"评级，目标价从57美元升至59美元</
06-11 09:43
